Cardiac Marker Testing Market Size, Share, Trends, Industry Analysis Report: By Product, Biomarker Type, End User, and Region

Description

List of Tables

The cardiac marker testing market size is expected to reach USD 11,771.28 million by 2034, according to a new study by Polaris Market Research. The report "Cardiac Marker Testing Market Size, Share, Trends, Industry Analysis Report: By Product (Reagents & Kits and Instruments), Biomarker Type, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Cardiac marker testing is a diagnostic process used to measure specific biomarkers in the blood that indicate cardiac conditions such as myocardial infarction, heart failure, and acute coronary syndrome. The market is experiencing growth due to the rising prevalence of cardiovascular diseases, increasing demand for high-sensitivity diagnostic tests, and advancements in point-of-care testing solutions. Key drivers include the aging population, growing awareness of early disease detection, and the integration of artificial intelligence (AI) in diagnostics.

Cardiac marker testing market opportunities exist in emerging markets where healthcare infrastructure is expanding. Further, trends such as multiplex assays and personalized medicine are shaping the market landscape. Overall, continuous innovation, regulatory approvals, and strategic collaborations are fueling market expansion and improving diagnostic accuracy for better patient outcomes.

Cardiac Marker Testing Market Report Highlights

The cardiac marker testing market, by product, is segmented into reagents & kits and instruments. The reagents & kits segment dominated the cardiac marker testing market share in 2024. This dominance is attributed to their widespread use in laboratory settings, offering high sensitivity and specificity in detecting cardiac biomarkers, which ensures accurate diagnosis of cardiovascular conditions.
The cardiac marker testing market, based on biomarker type, is segmented into troponin I & T, creatine kinase-MB (CK-MB), natriuretic peptide, myoglobin, high sensitivity c-reactive protein, and other cardiac biomarkers. The troponin I & T segment dominated the market share in 2024. Troponins are highly specific and sensitive biomarkers for myocardial injury, making them the preferred choice for diagnosing acute coronary syndromes.
By end user, the laboratory testing facilities segment accounts for the largest share due to widespread adoption in hospitals and diagnostic centers. However, the point-of-care testing facilities segment is growing rapidly due to the rising demand for quick and portable testing solutions.
North America dominated the cardiac marker testing market revenue share in 2024, driven by well-established healthcare infrastructure and high adoption of advanced diagnostics. However, Asia Pacific is the fastest-growing regional market due to increasing cardiovascular disease prevalence and expanding healthcare access.
Several key players in the cardiac marker testing market are actively contributing to advancements in diagnostic solutions. These include Abbott Laboratories; F. Hoffmann-La Roche Ltd.; Siemens Healthineers AG; Danaher Corporation; bioMerieux SA; Ortho Clinical Diagnostics; Randox Laboratories Ltd.; Beckman Coulter, Inc. (a subsidiary of Danaher Corporation); DiaSorin S.p.A.; Thermo Fisher Scientific Inc.; Becton, Dickinson and Company; PerkinElmer Inc.; Quidel Corporation; CardioGenics Holdings Inc.; and LSI Medience Corporation.

Polaris Market Research has segmented the cardiac marker testing market report on the basis of product, biomarker type, end user, and region:

By Product Outlook (Revenue - USD Million, 2020-2034)

Reagents & Kits
Instruments

By Biomarker Type Outlook (Revenue - USD Million, 2020-2034)

Troponin I & T
Creatine Kinase-MB (CK-MB)
Natriuretic Peptide
Myoglobin
High Sensitivity C-Reactive Protein
Other Cardiac Biomarkers

By End User Outlook (Revenue - USD Million, 2020-2034)

Laboratory Testing Facilities
Point-of-Care Testing Facilities
Academic Institutions

By Regional Outlook (Revenue - USD Million, 2020-2034)

North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America

Product Code: PM3322

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Source
- 3.2.1. Primary Source
- 3.2.2. Secondary Source

4. Global Cardiac Marker Testing Market Insights

4.1. Cardiac Marker Testing Market - Market Snapshot
4.2. Cardiac Marker Testing Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Increasing prevalence of cardiovascular diseases
  - 4.2.1.2. Advancements in point-of-care testing technologies
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High Cost of Advanced Tests
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Cardiac Marker Testing Market Application Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Cardiac Marker Testing Market, by Product

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Cardiac Marker Testing Market, by Product, 2020-2034 (USD Million)
5.3. Reagents & Kits
- 5.3.1. Global Cardiac Marker Testing Market, by Reagents & Kits, by Region, 2020-2034 (USD Million)
5.4. Instruments
- 5.4.1. Global Cardiac Marker Testing Market, by Instruments, by Region, 2020-2034 (USD Million)

6. Global Cardiac Marker Testing Market, by Biomarker Type

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Cardiac Marker Testing Market, by Biomarker Type, 2020-2034 (USD Million)
6.3. Troponin I & T
- 6.3.1. Global Cardiac Marker Testing Market, by Troponin I & T, by Region, 2020-2034 (USD Million)
6.4. Creatine Kinase-MB (CK-MB)
- 6.4.1. Global Cardiac Marker Testing Market, by Creatine Kinase-MB (CK-MB), by Region, 2020-2034 (USD Million)
6.5. Natriuretic Peptide
- 6.5.1. Global Cardiac Marker Testing Market, by Natriuretic Peptide, by Region, 2020-2034 (USD Million)
6.6. Myoglobin
- 6.6.1. Global Cardiac Marker Testing Market, by Myoglobin, by Region, 2020-2034 (USD Million)
6.7. High Sensitivity C-Reactive Protein
- 6.7.1. Global Cardiac Marker Testing Market, by High Sensitivity C-Reactive Protein, by Region, 2020-2034 (USD Million)
6.8. Other Cardiac Biomarkers
- 6.8.1. Global Cardiac Marker Testing Market, by Other Cardiac Biomarkers, by Region, 2020-2034 (USD Million)

7. Global Cardiac Marker Testing Market, by End-User

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Cardiac Marker Testing Market, by End-User, 2020-2034 (USD Million)
7.3. Laboratory Testing Facilities
- 7.3.1. Global Cardiac Marker Testing Market, by Laboratory Testing Facilities, by Region, 2020-2034 (USD Million)
7.4. Point-Of-Care Testing Facilities
- 7.4.1. Global Cardiac Marker Testing Market, by Point-Of-Care Testing Facilities, by Region, 2020-2034 (USD Million)
7.5. Academic Institutions
- 7.5.1. Global Cardiac Marker Testing Market, by Academic Institutions, by Region, 2020-2034 (USD Million)

8. Global Cardiac Marker Testing Market, by Geography

8.1. Key Findings
8.2. Introduction
- 8.2.1. Cardiac Marker Testing Market Assessment, By Geography, 2020-2034 (USD Million)
8.3. Cardiac Marker Testing Market - North America
- 8.3.1. North America: Cardiac Marker Testing Market, by Product, 2020-2034 (USD Million)
- 8.3.2. North America: Cardiac Marker Testing Market, by Biomarker Type, 2020-2034 (USD Million)
- 8.3.3. North America: Cardiac Marker Testing Market, by End-User, 2020-2034 (USD Million)
- 8.3.4. Cardiac Marker Testing Market - U.S.
  - 8.3.4.1. U.S.: Cardiac Marker Testing Market, by Product, 2020-2034 (USD Million)
  - 8.3.4.2. U.S.: Cardiac Marker Testing Market, by Biomarker Type, 2020-2034 (USD Million)
  - 8.3.4.3. U.S.: Cardiac Marker Testing Market, by End-User, 2020-2034 (USD Million)
- 8.3.5. Cardiac Marker Testing Market - Canada
  - 8.3.5.1. Canada: Cardiac Marker Testing Market, by Product, 2020-2034 (USD Million)
  - 8.3.5.2. Canada: Cardiac Marker Testing Market, by Biomarker Type, 2020-2034 (USD Million)
  - 8.3.5.3. Canada: Cardiac Marker Testing Market, by End-User, 2020-2034 (USD Million)
8.4. Cardiac Marker Testing Market - Europe
- 8.4.1. Europe: Cardiac Marker Testing Market, by Product, 2020-2034 (USD Million)
- 8.4.2. Europe: Cardiac Marker Testing Market, by Biomarker Type, 2020-2034 (USD Million)
- 8.4.3. Europe: Cardiac Marker Testing Market, by End-User, 2020-2034 (USD Million)
- 8.4.4. Cardiac Marker Testing Market - UK
  - 8.4.4.1. UK: Cardiac Marker Testing Market, by Product, 2020-2034 (USD Million)
  - 8.4.4.2. UK: Cardiac Marker Testing Market, by Biomarker Type, 2020-2034 (USD Million)
  - 8.4.4.3. UK: Cardiac Marker Testing Market, by End-User, 2020-2034 (USD Million)
- 8.4.5. Cardiac Marker Testing Market - France
  - 8.4.5.1. France: Cardiac Marker Testing Market, by Product, 2020-2034 (USD Million)
  - 8.4.5.2. France: Cardiac Marker Testing Market, by Biomarker Type, 2020-2034 (USD Million)
  - 8.4.5.3. France: Cardiac Marker Testing Market, by End-User, 2020-2034 (USD Million)
- 8.4.6. Cardiac Marker Testing Market - Germany
  - 8.4.6.1. Germany: Cardiac Marker Testing Market, by Product, 2020-2034 (USD Million)
  - 8.4.6.2. Germany: Cardiac Marker Testing Market, by Biomarker Type, 2020-2034 (USD Million)
  - 8.4.6.3. Germany: Cardiac Marker Testing Market, by End-User, 2020-2034 (USD Million)
- 8.4.7. Cardiac Marker Testing Market - Italy
  - 8.4.7.1. Italy: Cardiac Marker Testing Market, by Product, 2020-2034 (USD Million)
  - 8.4.7.2. Italy: Cardiac Marker Testing Market, by Biomarker Type, 2020-2034 (USD Million)
  - 8.4.7.3. Italy: Cardiac Marker Testing Market, by End-User, 2020-2034 (USD Million)
- 8.4.8. Cardiac Marker Testing Market - Spain
  - 8.4.8.1. Spain: Cardiac Marker Testing Market, by Product, 2020-2034 (USD Million)
  - 8.4.8.2. Spain: Cardiac Marker Testing Market, by Biomarker Type, 2020-2034 (USD Million)
  - 8.4.8.3. Spain: Cardiac Marker Testing Market, by End-User, 2020-2034 (USD Million)
- 8.4.9. Cardiac Marker Testing Market - Netherlands
  - 8.4.9.1. Netherlands: Cardiac Marker Testing Market, by Product, 2020-2034 (USD Million)
  - 8.4.9.2. Netherlands: Cardiac Marker Testing Market, by Biomarker Type, 2020-2034 (USD Million)
  - 8.4.9.3. Netherlands: Cardiac Marker Testing Market, by End-User, 2020-2034 (USD Million)
- 8.4.10. Cardiac Marker Testing Market - Russia
  - 8.4.10.1. Russia: Cardiac Marker Testing Market, by Product, 2020-2034 (USD Million)
  - 8.4.10.2. Russia: Cardiac Marker Testing Market, by Biomarker Type, 2020-2034 (USD Million)
  - 8.4.10.3. Russia: Cardiac Marker Testing Market, by End-User, 2020-2034 (USD Million)
- 8.4.11. Cardiac Marker Testing Market - Rest of Europe
  - 8.4.11.1. Rest of Europe: Cardiac Marker Testing Market, by Product, 2020-2034 (USD Million)
  - 8.4.11.2. Rest of Europe: Cardiac Marker Testing Market, by Biomarker Type, 2020-2034 (USD Million)
  - 8.4.11.3. Rest of Europe: Cardiac Marker Testing Market, by End-User, 2020-2034 (USD Million)
8.5. Cardiac Marker Testing Market - Asia Pacific
- 8.5.1. Asia Pacific: Cardiac Marker Testing Market, by Product, 2020-2034 (USD Million)
- 8.5.2. Asia Pacific: Cardiac Marker Testing Market, by Biomarker Type, 2020-2034 (USD Million)
- 8.5.3. Asia Pacific: Cardiac Marker Testing Market, by End-User, 2020-2034 (USD Million)
- 8.5.4. Cardiac Marker Testing Market - China
  - 8.5.4.1. China: Cardiac Marker Testing Market, by Product, 2020-2034 (USD Million)
  - 8.5.4.2. China: Cardiac Marker Testing Market, by Biomarker Type, 2020-2034 (USD Million)
  - 8.5.4.3. China: Cardiac Marker Testing Market, by End-User, 2020-2034 (USD Million)
- 8.5.5. Cardiac Marker Testing Market - India
  - 8.5.5.1. India: Cardiac Marker Testing Market, by Product, 2020-2034 (USD Million)
  - 8.5.5.2. India: Cardiac Marker Testing Market, by Biomarker Type, 2020-2034 (USD Million)
  - 8.5.5.3. India: Cardiac Marker Testing Market, by End-User, 2020-2034 (USD Million)
- 8.5.6. Cardiac Marker Testing Market - Malaysia
  - 8.5.6.1. Malaysia: Cardiac Marker Testing Market, by Product, 2020-2034 (USD Million)
  - 8.5.6.2. Malaysia: Cardiac Marker Testing Market, by Biomarker Type, 2020-2034 (USD Million)
  - 8.5.6.3. Malaysia: Cardiac Marker Testing Market, by End-User, 2020-2034 (USD Million)
- 8.5.7. Cardiac Marker Testing Market - Japan
  - 8.5.7.1. Japan: Cardiac Marker Testing Market, by Product, 2020-2034 (USD Million)
  - 8.5.7.2. Japan: Cardiac Marker Testing Market, by Biomarker Type, 2020-2034 (USD Million)
  - 8.5.7.3. Japan: Cardiac Marker Testing Market, by End-User, 2020-2034 (USD Million)
- 8.5.8. Cardiac Marker Testing Market - Indonesia
  - 8.5.8.1. Indonesia: Cardiac Marker Testing Market, by Product, 2020-2034 (USD Million)
  - 8.5.8.2. Indonesia: Cardiac Marker Testing Market, by Biomarker Type, 2020-2034 (USD Million)
  - 8.5.8.3. Indonesia: Cardiac Marker Testing Market, by End-User, 2020-2034 (USD Million)
- 8.5.9. Cardiac Marker Testing Market - South Korea
  - 8.5.9.1. South Korea: Cardiac Marker Testing Market, by Product, 2020-2034 (USD Million)
  - 8.5.9.2. South Korea: Cardiac Marker Testing Market, by Biomarker Type, 2020-2034 (USD Million)
  - 8.5.9.3. South Korea: Cardiac Marker Testing Market, by End-User, 2020-2034 (USD Million)
- 8.5.10. Cardiac Marker Testing Market - Australia
  - 8.5.10.1. Australia: Cardiac Marker Testing Market, by Product, 2020-2034 (USD Million)
  - 8.5.10.2. Australia: Cardiac Marker Testing Market, by Biomarker Type, 2020-2034 (USD Million)
  - 8.5.10.3. Australia: Cardiac Marker Testing Market, by End-User, 2020-2034 (USD Million)
- 8.5.11. Cardiac Marker Testing Market - Rest of Asia Pacific
  - 8.5.11.1. Rest of Asia Pacific: Cardiac Marker Testing Market, by Product, 2020-2034 (USD Million)
  - 8.5.11.2. Rest of Asia Pacific: Cardiac Marker Testing Market, by Biomarker Type, 2020-2034 (USD Million)
  - 8.5.11.3. Rest of Asia Pacific: Cardiac Marker Testing Market, by End-User, 2020-2034 (USD Million)
8.6. Cardiac Marker Testing Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Cardiac Marker Testing Market, by Product, 2020-2034 (USD Million)
- 8.6.2. Middle East & Africa: Cardiac Marker Testing Market, by Biomarker Type, 2020-2034 (USD Million)
- 8.6.3. Middle East & Africa: Cardiac Marker Testing Market, by End-User, 2020-2034 (USD Million)
- 8.6.4. Cardiac Marker Testing Market - Saudi Arabia
  - 8.6.4.1. Saudi Arabia: Cardiac Marker Testing Market, by Product, 2020-2034 (USD Million)
  - 8.6.4.2. Saudi Arabia: Cardiac Marker Testing Market, by Biomarker Type, 2020-2034 (USD Million)
  - 8.6.4.3. Saudi Arabia: Cardiac Marker Testing Market, by End-User, 2020-2034 (USD Million)
- 8.6.5. Cardiac Marker Testing Market - UAE
  - 8.6.5.1. UAE: Cardiac Marker Testing Market, by Product, 2020-2034 (USD Million)
  - 8.6.5.2. UAE: Cardiac Marker Testing Market, by Biomarker Type, 2020-2034 (USD Million)
  - 8.6.5.3. UAE: Cardiac Marker Testing Market, by End-User, 2020-2034 (USD Million)
- 8.6.6. Cardiac Marker Testing Market - Israel
  - 8.6.6.1. Israel: Cardiac Marker Testing Market, by Product, 2020-2034 (USD Million)
  - 8.6.6.2. Israel: Cardiac Marker Testing Market, by Biomarker Type, 2020-2034 (USD Million)
  - 8.6.6.3. Israel: Cardiac Marker Testing Market, by End-User, 2020-2034 (USD Million)
- 8.6.7. Cardiac Marker Testing Market - South Africa
  - 8.6.7.1. South Africa: Cardiac Marker Testing Market, by Product, 2020-2034 (USD Million)
  - 8.6.7.2. South Africa: Cardiac Marker Testing Market, by Biomarker Type, 2020-2034 (USD Million)
  - 8.6.7.3. South Africa: Cardiac Marker Testing Market, by End-User, 2020-2034 (USD Million)
- 8.6.8. Cardiac Marker Testing Market - Rest of Middle East & Africa
  - 8.6.8.1. Rest of Middle East & Africa: Cardiac Marker Testing Market, by Product, 2020-2034 (USD Million)
  - 8.6.8.2. Rest of Middle East & Africa: Cardiac Marker Testing Market, by Biomarker Type, 2020-2034 (USD Million)
  - 8.6.8.3. Rest of Middle East & Africa: Cardiac Marker Testing Market, by End-User, 2020-2034 (USD Million)
8.7. Cardiac Marker Testing Market - Latin America
- 8.7.1. Latin America: Cardiac Marker Testing Market, by Product, 2020-2034 (USD Million)
- 8.7.2. Latin America: Cardiac Marker Testing Market, by Biomarker Type, 2020-2034 (USD Million)
- 8.7.3. Latin America: Cardiac Marker Testing Market, by End-User, 2020-2034 (USD Million)
- 8.7.4. Cardiac Marker Testing Market - Mexico
  - 8.7.4.1. Mexico: Cardiac Marker Testing Market, by Product, 2020-2034 (USD Million)
  - 8.7.4.2. Mexico: Cardiac Marker Testing Market, by Biomarker Type, 2020-2034 (USD Million)
  - 8.7.4.3. Mexico: Cardiac Marker Testing Market, by End-User, 2020-2034 (USD Million)
- 8.7.5. Cardiac Marker Testing Market - Brazil
  - 8.7.5.1. Brazil: Cardiac Marker Testing Market, by Product, 2020-2034 (USD Million)
  - 8.7.5.2. Brazil: Cardiac Marker Testing Market, by Biomarker Type, 2020-2034 (USD Million)
  - 8.7.5.3. Brazil: Cardiac Marker Testing Market, by End-User, 2020-2034 (USD Million)
- 8.7.6. Cardiac Marker Testing Market - Argentina
  - 8.7.6.1. Argentina: Cardiac Marker Testing Market, by Product, 2020-2034 (USD Million)
  - 8.7.6.2. Argentina: Cardiac Marker Testing Market, by Biomarker Type, 2020-2034 (USD Million)
  - 8.7.6.3. Argentina: Cardiac Marker Testing Market, by End-User, 2020-2034 (USD Million)
- 8.7.7. Cardiac Marker Testing Market - Rest of Latin America
  - 8.7.7.1. Rest of Latin America: Cardiac Marker Testing Market, by Product, 2020-2034 (USD Million)
  - 8.7.7.2. Rest of Latin America: Cardiac Marker Testing Market, by Biomarker Type, 2020-2034 (USD Million)
  - 8.7.7.3. Rest of Latin America: Cardiac Marker Testing Market, by End-User, 2020-2034 (USD Million)

9. Competitive Landscape

9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. Abbott Laboratories
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
10.2. Beckman Coulter, Inc. (a subsidiary of Danaher Corporation)
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
10.3. Becton, Dickinson and Company
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
10.4. bioMerieux SA
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
10.5. CardioGenics Holdings Inc.
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
10.6. Danaher Corporation
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
10.7. DiaSorin S.p.A.
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
10.8. F. Hoffmann-La Roche Ltd.
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
10.9. LSI Medience Corporation
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
10.10. Ortho Clinical Diagnostics
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development